Results 141 to 150 of about 12,091 (224)

Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials. [PDF]

Drug Saf, 2021
Hey-Hadavi J, Seekins D, Palmer M, Coffey D, Caminis J, Abdullaev S, Patwardhan M, Tyler H, Raheja R, Stanley AM, Pineda-Salgado L, Bourdet DL, Andrade RJ, Hayashi PH, Dimick-Santos L, Rockey DC, Estilo A.   +16 more
europepmc   +1 more source

Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment. [PDF]

Ann Pharmacother, 2021
Danjuma M, Elgara M, Al-Hattab F, Abaro R, Elzouki AN.   +4 more
europepmc   +1 more source

Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure. [PDF]

Biol Direct, 2021
Liu A, Walter M, Wright P, Bartosik A, Dolciami D, Elbasir A, Yang H, Bender A.   +7 more
europepmc   +1 more source

Esbriet Pirfenidon medikamenteninduzierte Leberschdigung Drug-induced liver injury DILI [PDF]

Schweizerische Ärztezeitung, 2020
openaire   +1 more source

Puromycin-based purification of cells with high expression of the cytochrome P450 CYP3A4 gene from a patient with drug-induced liver injury (DILI). [PDF]

Stem Cell Res Ther, 2022
Miyata S, Saku N, Akiyama S, Javaregowda PK, Ite K, Takashima N, Toyoda M, Yura K, Kimura T, Nishina H, Nakazawa A, Kasahara M, Nonaka H, Kiyono T, Umezawa A.   +14 more
europepmc   +1 more source

Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. [PDF]

Antioxidants (Basel), 2021
Villanueva-Paz M, Morán L, López-Alcántara N, Freixo C, Andrade RJ, Lucena MI, Cubero FJ.   +6 more
europepmc   +1 more source

Using free-text searching and ICD-10 codes to identify prospective patients with drug-induced liver injury [PDF]

, 2016
Drug-induced liver injury (DILI) is a rare cause of liver disease that is difficult to diagnose due to the lack of a confirmatory test. The Drug-Induced Liver Injury Network (DILIN) was developed to enroll patients with DILI to understand the clinical ...
Coffman, Cassandra
core   +1 more source

Drug Induced Liver Injury (DILI): a short review

Istanbul Journal of Pharmacy, 2017
Muzeyyen Celikoz, Buket Hun, Gul Ozhan
openaire   +2 more sources

Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab [PDF]

, 2016
BACKGROUND: Abnormal liver enzymes are frequently encountered in inflammatory bowel disease (IBD) patients. Infliximab has been implicated in inducing drug-induced liver injury, autoimmune hepatitis or reactivation of hepatitis B virus.
Burroughs, AK, Epstein, O, Hamilton, M, Manousou, P, Murray, C, O'Beirne, J, Parisi, I, Rossi, RE, Theocharidou, E, Tsochatzis, E   +9 more
core  

Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM). [PDF]

Diagnostics (Basel), 2021
Teschke R, Danan G.
europepmc   +1 more source